Clinical Trial Update: Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the optimal concentrations of remifentanil and dexmedetomidine for uterine fibroid ablation; the study is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Remifentanil (remifentanil)

Snippet

Sponsor: Kaohsiung Medical University | Conditions: Uterine Fibroids (UF) | Phase 4 | Status: NOT_YET_RECRUITING